首页> 外文期刊>Open Forum Infectious Diseases >A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings
【24h】

A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings

机译:在不同的跨国环境中,拟和基于依法韦伦茨的抗逆转录病毒疗法拟人变化的随机比较

获取原文
       

摘要

Background.?Existing data on anthropomorphic changes in resource-limited settings primarily come from observational or cross-sectional studies. Data from randomized clinical trials are needed to inform treatment decisions in these areas of the world. Methods.?The AIDS Clinical Trials Group Prospective Evaluation of Antiretrovirals in Resource-Limited Settings (PEARLS) study was a prospective, randomized evaluation of the efficacy of emtricitabine/tenofovir + efavirenz (FTC/TDF + EFV) vs lamivudine/zidovudine + efavirenz (3TC/ZDV + EFV) for the initial treatment of human immunodeficiency virus (HIV)-1-infected individuals from resource-diverse settings. Changes in anthropomorphic measures were analyzed using mixed-effect models for repeated measurements, using all available measurements at weeks 48, 96, and 144. Intent-to-treat results are presented; as-treated results were similar. Results.?Five hundred twenty-six participants were randomized to FTC/TDF + EFV, and 519 participants were randomized to 3TC/ZDV + EFV. Significantly greater increases from baseline to week 144 were seen among those randomized to FTC/TDF + EFV vs 3TC/ZDV + EFV in all measures except waist-to-hip ratio, with the following mean changes: weight, 4.8 vs 3.0 kg; body mass index, 1.8 vs 1.1 kg/m2; mid-arm, 1.7 vs 0.7 cm; waist, 5.2 vs 4.3 cm; hip, 3.8 vs 1.4 cm; and mid-thigh circumference, 3.1 vs 0.9 cm. There were 7 clinical diagnoses of lipoatrophy in the 3TC/ZDV + EFV arm compared with none in the FTC/TDF + EFV arm. The proportion of overweight or obese participants increased from 25% (week 0) to 42% (week 144) for FTC/TDF + EFV and from 26% to 38% for 3TC/ZDV + EFV. Conclusions.?Our findings support first-line use of FTC/TDF + EFV in resource-limited settings and emphasize the need for interventions to limit weight gain among overweight or obese HIV-infected participants in all settings.
机译:背景:关于资源有限的环境中拟人化变化的现有数据主要来自观察或横断面研究。需要来自随机临床试验的数据来为世界上这些地区的治疗决策提供依据。方法:艾滋病临床试验小组在资源有限的环境中对抗逆转录病毒药物的前瞻性评估是对恩曲他滨/替诺福韦+依非韦伦(FTC / TDF + EFV)与拉米夫定/齐多夫定+依非韦伦(( 3TC / ZDV + EFV)用于从资源多样化的环境中初步治疗人类免疫缺陷病毒(HIV)-1感染的个体。使用混合效应模型对拟人化测量值的变化进行了重复测量,并在第48、96和144周使用了所有可用的测量值。治疗结果相似。结果:256名参与者被随机分为FTC / TDF + EFV,519名参与者被随机分为3TC / ZDV + EFV。从基线到第144周,在除腰臀比以外的所有指标中,随机分配到FTC / TDF + EFV与3TC / ZDV + EFV的患者中,观察到的增加更大,平均变化如下:体重,4.8 vs. 3.0 kg;体重指数1.8 vs 1.1 kg / m 2 ;手臂中部,1.7对0.7厘米;腰围5.2和4.3厘米;臀围3.8对1.4厘米;大腿中部围:3.1厘米和0.9厘米。 3TC / ZDV + EFV组有7例临床诊断为脂肪萎缩,而FTC / TDF + EFV组则无此诊断。 FTC / TDF + EFV的超重或肥胖参与者比例从25%(第0周)增加到42%(144周),而3TC / ZDV + EFV从26%增加到38%。结论:我们的发现支持在资源有限的环境中一线使用FTC / TDF + EFV,并强调需要采取干预措施来限制所有环境中超重或肥胖的HIV感染者的体重增加。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号